Current understanding of the cardiotoxicity-related treatment of immune checkpoint inhibitors in breast cancer
<p>Immune Checkpoint Inhibitors (ICIs) as the most important and widely used currently, have changed the traditional approach to cancer treatment and significantly improved the prognosis of most patients with advanced malignancies. Breast cancer is the most dangerous threatening tumor to women...
Saved in:
Main Author: | Jiajing Dai (Author) |
---|---|
Format: | Book |
Published: |
International Journal of Immunotherapy and Cancer Research - Peertechz Publications,
2023-05-03.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management
by: Yu-Wen Zhou, et al.
Published: (2019) -
Cardiotoxicity associated with immune checkpoint inhibitors: Current status and future challenges
by: Lu Gan, et al.
Published: (2022) -
Cardiotoxicity mechanisms of antitumor therapy with immune checkpoint inhibitors: new achievements
by: L. D. Khidirova, et al.
Published: (2024) -
An overview of immune checkpoint inhibitors in breast cancer
by: Federica Miglietta, et al.
Published: (2020) -
Cardiotoxicity Induced by Immune Checkpoint Inhibitors: A Pharmacovigilance Study From 2014 to 2019 Based on FAERS
by: Chenxin Chen, et al.
Published: (2021)